tiprankstipranks
Sabra Healthcare Reit (DE:SBC)
NASDAQ:SBC
Germany Market

Sabra Healthcare REIT (SBC) Earnings Dates, Call Summary & Reports

0 Followers

Earnings Data

Report Date
Aug 10, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.14
Last Year’s EPS
0.23
Same Quarter Last Year
Based on 8 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 29, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized strong and accelerating SHOP deal flow and operating performance (notably robust same-store revenue, occupancy, RevPAR, and NOI growth), record private-pay concentration, healthy FFO/AFFO growth, solid liquidity, and disciplined capital use (forward equity locks). Key negatives are limited and include certain asset transitions (Holiday assets), legal/sale process for Landmark behavioral assets, a highly competitive skilled nursing acquisition market that limits SNF opportunities, modest increases in G&A and the reaffirmation of guidance (conservative stance) with a plan to reassess in Q2. On balance, the positive operating trends, material pipeline, and balance-sheet flexibility outweigh the risks and uncertainties discussed.
Company Guidance
Sabra reaffirmed its 2026 earnings guidance (to be revisited in Q2) after reporting Q1 normalized FFO per share of $0.38 and normalized AFFO per share of $0.39 (up 9% and 5% YoY), totaling $96.1M and $100.6M, and declaring a $0.30 quarterly dividend (covered at 77% of Q1 normalized AFFO). Management highlighted strong investment activity—~$400M closed or awarded YTD, $102M invested in Q1 (and ~$14.1M post-quarter) bringing YTD to ~$206M with an estimated initial cash yield of 8%; an additional $107M (managed SHOP) and $94M (skilled) are awarded to close in Q2 and ~$690M of SHOP opportunities are being pursued. Same-store SHOP metrics underpinning the outlook include revenue +7.9% YoY, occupancy +280 bps to 88.4% (U.S. 85.6%, Canada 93.4%), RevPAR +4.6% and same-store cash NOI +14.4% YoY (total managed SHOP quarter revenue +7.2% sequential, cash NOI +9.5% and margin expansion +60 bps). Balance-sheet and financing stats supporting the plan: net debt/adjusted EBITDA 5.04x, cost of permanent debt 3.92% with ~4 years weighted average term, ~no permanent floating-rate exposure, liquidity ~ $1.2B (cash $117M, revolver $645M, $451M outstanding forward sales under ATM and $353M available), $451M of forwards issued (avg $19.03) plus $128M issued this quarter (avg $20.19), and recent dispositions of three SNFs for $79.4M (6.8% lease yield).
Robust Deal Flow and Investment Activity
Company reported strong pipeline and deal flow: stated $400 million closed or awarded year-to-date; invested $102 million in Q1 and an additional $14.1 million subsequent to quarter end (management referenced roughly $206 million of year-to-date investments), with another $107 million of awarded managed senior housing and $94 million of awarded skilled nursing expected to close mostly in Q2, and an active $690 million of additional managed senior housing opportunities being pursued.
Managed Senior Housing Sequential Operating Strength
Total managed senior housing portfolio (including non-stabilized and JV share) produced sequential revenue growth of 7.2%, cash NOI growth of 9.5%, and margin expansion of 60 basis points.
Same-Store SHOP Year-over-Year Outperformance
Same-store managed senior housing revenue grew 7.9% YoY; occupancy rose 280 basis points YoY to 88.4% (domestic 85.6%, Canada 93.4%); RevPAR increased 4.6% YoY (Canada +6.5%); expense per occupied room rose only 1.8% YoY; resulting in cash NOI growth of 14.4% YoY.
FFO / AFFO Growth
Q1 normalized FFO per share was $0.38 (+9% YoY) and normalized AFFO per share was $0.39 (+5% YoY); in absolute terms normalized FFO totaled $96.1 million and normalized AFFO totaled $100.6 million.
Private-Pay Mix Milestone
For the first time in company history private-pay concentration reached 50% of the portfolio, a material strategic shift toward higher private-pay exposure.
Improving Triple-Net and Consolidated Cash NOI
Cash NOI from triple-net portfolio increased $2.2 million sequentially; managed senior housing cash NOI was $39.0 million this quarter versus $35.6 million last quarter (a $3.4 million increase), reflecting investment activity and same-store growth.
Strong Liquidity and Proactive Capital Management
Reported liquidity of approximately $1.2 billion (unrestricted cash $117 million, $645 million available on revolving credit facility, $451 million outstanding under forward sales agreements, plus $353 million available under ATM). Issued $128 million on a forward basis at an average price of $20.19 per share and have $451 million outstanding under forward contracts at an average price of $19.03 per share.
Healthy Balance Sheet Metrics and Low Fixed-Rate Cost
Net debt to adjusted EBITDA was 5.04x as of 03/31/2026 (in line with target). Cost of permanent debt averaged 3.92% with a weighted average remaining term of ~4 years and the next material maturity in 2028; no floating-rate permanent debt exposure.
Dividend Declared with Coverage
Board declared quarterly cash dividend of $0.30 per share to be paid 05/29/2026; dividend is covered at 77% of first-quarter normalized AFFO per share.

Sabra Healthcare REIT (DE:SBC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:SBC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 10, 2026
2026 (Q2)
0.14 / -
0.232
Apr 29, 2026
2026 (Q1)
0.14 / 0.14
0.146-5.88% (>-0.01)
Feb 12, 2026
2025 (Q4)
0.14 / 0.09
0.164-42.11% (-0.07)
Nov 05, 2025
2025 (Q3)
0.16 / 0.08
0.112-30.77% (-0.03)
Aug 04, 2025
2025 (Q2)
0.15 / 0.23
0.086170.00% (+0.15)
May 05, 2025
2025 (Q1)
0.15 / 0.15
0.09554.55% (+0.05)
Feb 19, 2025
2024 (Q4)
0.14 / 0.16
0.06171.43% (+0.10)
Oct 31, 2024
2024 (Q3)
0.14 / 0.11
-0.06285.71% (+0.17)
Aug 07, 2024
2024 (Q2)
0.13 / 0.09
0.07711.11% (<+0.01)
May 08, 2024
2024 (Q1)
0.12 / 0.09
-0.034375.00% (+0.13)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:SBC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 29, 2026
€17.11€16.89-1.29%
Feb 12, 2026
€15.76€16.69+5.90%
Nov 05, 2025
€14.76€14.60-1.13%
Aug 04, 2025
€14.69€14.80+0.70%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sabra Healthcare Reit (DE:SBC) report earnings?
Sabra Healthcare Reit (DE:SBC) is schdueled to report earning on Aug 10, 2026, TBA (Confirmed).
    What is Sabra Healthcare Reit (DE:SBC) earnings time?
    Sabra Healthcare Reit (DE:SBC) earnings time is at Aug 10, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Sabra Healthcare Reit stock?
          The P/E ratio of Sabra Healthcare REIT is N/A.
            What is DE:SBC EPS forecast?
            DE:SBC EPS forecast for the fiscal quarter 2026 (Q2) is 0.14.